Hepatocyte Production via Transcription Factor Programming
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing hepatocytes are limited by the scarcity of primary human hepatocytes, their short lifespan, and the immaturity of hepatocyte-like cells derived from human pluripotent stem cells, which lack the full repertoire of functions of mature hepatocytes, making it challenging to develop fully functional hepatocytes in vitro.
Innovation Solution
A method involving the forward programming of human pluripotent stem cells using a set of transcription factors including HNF1A, HNF6, FOXA3, and RORc, optionally with ERα, to induce a mature hepatocyte phenotype, bypassing the need for complex differentiation pathways and lengthy timelines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If primary human hepatocytes are used for therapy, then therapeutic effectiveness is improved, but supply scarcity and short lifespan worsen the applicability
Solution Approach 1:
The patent creates functional copies of mature hepatocytes by programming pluripotent stem cells with a defined set of transcription factors (HNF1A, HNF6, FOXA3, RORc, and ERα). These induced hepatocytes replicate the functional capabilities of primary hepatocytes including protein secretion, lipid metabolism, and detoxification, while being producible in unlimited quantities through stem cell expansion
Solution Approach 2:
The patent fundamentally changes the developmental parameters by using forward programming to skip intermediate differentiation stages. Instead of allowing natural maturation over months, the transcription factor cocktail directly programs pluripotent cells to adopt a mature hepatocyte phenotype, dramatically accelerating the timeline while maintaining functional maturity
2Productivity
If directed differentiation protocols are used to produce hepatocyte-like cells, then production capability is improved, but functional immaturity worsens the applicability
Solution Approach 1:
The patent performs preliminary programming of the complete mature hepatocyte phenotype during the differentiation process itself. By pre-establishing the transcription factor profile (HNF1A, HNF6, FOXA3, RORc, ERα) in pluripotent cells before differentiation, the cells skip immature intermediate stages and directly become functionally mature hepatocytes capable of immediate therapeutic use
Solution Approach 2:
The patent combines multiple transcription factors (HNF1A, HNF6, FOXA3, RORc, and ERα) working synergistically to achieve complete hepatocyte maturation. This composite approach leverages the complementary functions of each factor: HNF1A and HNF6 for core hepatocyte identity, FOXA3 for developmental regulation, RORc for metabolic programming, and ERα for maturation, achieving comprehensive functional maturity that no single factor could achieve alone
Data Source
AI summary
This invention relates to a method of producing hepatocytes comprising introducing a set of transcription factors consisting of HNF1A; HNF6; FOXA3; RORc and ERα into a population of iPSCs, and culturing the population, such that hepatocytes are produced. Methods of producing hepatocytes, hepatocytes produced by the methods and their uses and applications are provided.